Your session is about to expire
← Back to Search
7T MRI Scan for Brain Cancer
N/A
Recruiting
Led By Max Wintermark
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult patients with newly identified and untreated central nervous system glioma or metastasis of at least 5 mm or greater in size
History of central nervous system glioma or metastasis treated with surgery, radiation, chemotherapy, or immunotherapy with new or increasing signal on MR imaging that is suspicious for progressive disease (treatment failure)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial tests if 7T MRI can detect central nervous system tumors better than standard MRI. It could help find & diagnose tumors and measure patient response to treatment.
Who is the study for?
This trial is for adults with new or suspected recurrent central nervous system tumors, including gliomas and metastases. Participants may have had previous treatments like surgery or chemotherapy. They must have a tumor of at least 5mm that's visible on an MRI scan and not be pregnant, claustrophobic, allergic to contrast agents used in MRIs, or have renal failure.Check my eligibility
What is being tested?
The study is testing the effectiveness of a high-resolution 7T MRI scan compared to standard MRI scans in detecting and monitoring brain tumors. It aims to determine if the newer technology provides clearer images for better diagnosis and treatment evaluation.See study design
What are the potential side effects?
There are generally no direct side effects from undergoing a 7T MRI scan itself; however, some individuals might experience discomfort due to lying still for long periods or anxiety within the confined space of the scanner.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a newly diagnosed brain tumor or cancer spread to the brain that is at least 5 mm.
Select...
I had brain cancer or cancer spread to my brain treated, but recent scans suggest it might be getting worse.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Contrast-to-noise ratio (CNR)
Secondary outcome measures
Conspicuity of each imaging modality to differentiate radiation necrosis from progressive disease
Other outcome measures
Functional (f)MRI paradigms
Patient satisfaction
Trial Design
1Treatment groups
Experimental Treatment
Group I: Diagnostic (7T MRI)Experimental Treatment2 Interventions
Patients undergo 7T MRI over 60 minutes.
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,974 Previous Clinical Trials
1,789,296 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,667 Previous Clinical Trials
40,926,032 Total Patients Enrolled
Max WintermarkPrincipal InvestigatorM.D. Anderson Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are unable to have a magnetic resonance imaging (MRI) scan for medical reasons.I have a newly diagnosed brain tumor or cancer spread to the brain that is at least 5 mm.My doctors suspect my cancer has returned and agree it looks like it's recurring.Experts agree I likely have a brain tumor or cancer spread to the brain.I have a history of cancer in a solid organ and may have cancer spread to my brain.You have certain types of implants or medical devices that can't be used with MRI machines, or you have conditions like pregnancy, kidney problems, or claustrophobia that can make getting an MRI unsafe for you.I had brain cancer or cancer spread to my brain treated, but recent scans suggest it might be getting worse.You have metal objects inside your body that could be unsafe during an MRI scan.
Research Study Groups:
This trial has the following groups:- Group 1: Diagnostic (7T MRI)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
To what extent have participants engaged in this medical experiment?
"Absolutely, the clinicaltrials.gov database shows that this trial is being conducted right now and opened for participation on September 4th 2020. The latest update was made March 13th 2023, with 100 patients sought from a single site."
Answered by AI
Is enrollment for this trial still available to individuals?
"According to the clinicaltrials.gov database, this medical experiment is actively seeking participants. The trial was initiated on September 4th 2020 and last modified on March 13th 2023."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger